SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-008774
Filing Date
2022-02-22
Accepted
2022-02-22 20:15:12
Documents
2
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1646
2 POWER OF ATTORNEY ea156052ex24_inmedpharma.htm EX-24 8115
  Complete submission text file 0001213900-22-008774.txt   11091
Mailing Address 510 WEST GEORGIA STREET, SUITE 1800 VANCOUVER A1 V5T 4T5
Business Address
Grove Janet P (Reporting) CIK: 0001355675 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 22660310

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations